Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
In vitro and in vivo evaluation of a humanized anti-APRIL antibody.
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia.
Interleukin 18 gene polymorphism is a risk factor for multiple sclerosis.
Multiple rodent models and behavioral measures reveal unexpected responses to FTY720 and DMF in experimental autoimmune encephalomyelitis.
Optical Coherence Tomography Detection of Neurodegeneration in Multiple Sclerosis.
Post-infective transverse myelitis following Streptococcus pneumoniae meningitis with radiological features of acute disseminated encephalomyelitis: a case report.
The therapeutic potential of cannabis and cannabinoids.
[Factorial structure of the dysexecutive questionnaire in a sample of the Spanish population with acquired brain injury and memory deficit complaints].
Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
Relation of helicobacter pylori infection and multiple sclerosis in Iranian patients.
Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl)amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent RORγt inhibitors.
Aquatherapy for neurodegenerative disorders.
PML in MS Patients Making Natalizumab-to-Fingolimod Switch
Vitamin D - immunomodulatory actions and new potentialities.
Pharyngeal electrical stimulation for dysphagia associated with multiple sclerosis: A pilot study.
Optic neuritis in a psoriatic arthritis patient treated by infliximab.
Efficient transdifferentiation of human adipose-derived stem cells into Schwann-like cells: A promise for treatment of demyelinating diseases.
Myelin oligodendrocyte glycoprotein induces aquaporin-4 autoantibodies in mouse experimental autoimmune encephalomyelitis.
Cholesterol Modification of p40-Specific Small Interfering RNA Enables Therapeutic Targeting of Dendritic Cells.
Association of Viruses in Neurodegenerative and Neurobehavioral Diseases.
Opexa Amends Agreement with Merck Serono and Receives Additional $3 Million Payment to Support Ongoing Development of Tcelna® for Multiple Sclerosis
Functional-structural correlations in the afferent visual pathway in pediatric demyelination.
Endoplasmic reticulum dysfunction in neurological disease.
[Magnetic reasonance spectroscopy-guided stereotactic biopsy for brain lesion].
High risk of cardiovascular diseases after diagnosis of multiple sclerosis.
Pages
« first
‹ previous
…
263
264
265
266
267
268
269
270
271
…
next ›
last »